Byrd John C. 4
4 · Vincera Pharma, Inc. · Filed Dec 28, 2020
Insider Transaction Report
Form 4
Byrd John C.
10% Owner
Transactions
- Award
Common Stock
2020-12-23+1,618,199→ 1,618,199 total
Footnotes (1)
- [F1]Received pursuant to the Merger Agreement, dated as of September 25, 2020, by and among LifeSci Acquisition Corp. ("LifeSci"), Vincera Pharma, Inc. ("Legacy Vincera") and LifeSci Acquisition Merger Sub, Inc., a wholly-owned subsidiary of LifeSci ("Merger Sub"), pursuant to which Merger Sub merged with and into Legacy Vincera, with Legacy Vincera surviving the merger as a wholly-owned subsidiary of LifeSci (which subsequently changed its name to "Vincera Pharma, Inc.").